HomeNAUT • NASDAQ
add
Nautilus Biotechnology Inc
Previous close
$1.77
Day range
$1.69 - $1.80
Year range
$1.61 - $3.10
Market cap
214.71M USD
Avg Volume
151.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.10M | 0.13% |
Net income | -16.45M | -3.58% |
Net profit margin | — | — |
Earnings per share | -0.13 | 0.00% |
EBITDA | -18.58M | 0.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 140.61M | -23.29% |
Total assets | 259.70M | -18.42% |
Total liabilities | 36.27M | -11.67% |
Total equity | 223.43M | — |
Shares outstanding | 125.56M | — |
Price to book | 0.99 | — |
Return on assets | -17.94% | — |
Return on capital | -18.26% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -16.45M | -3.58% |
Cash from operations | -13.11M | -11.71% |
Cash from investing | -7.50M | -157.38% |
Cash from financing | 140.00K | 775.00% |
Net change in cash | -20.48M | -1,613.38% |
Free cash flow | -8.12M | -8.20% |
About
Founded
2016
Headquarters
Website
Employees
161
